CCA Australia July 2022 Progress Update
A starting point for the next generation of cholangiocarcinoma patient success in Australia.
Intrahepatic Cholangiocarcinoma – Diagnosis and Treatment
Fralin Biomedical Research Institute Timothy Pawlik, M.D., Ph.D. dives deep into discovering and treating intrahepatic cholangiocarcinoma
World Cholangiocarcinoma Day
Contribution and Sharing are powerful human elements in the cancer cure equation - this is my contribution.
Treat the Immune not the Cancer
A breakthrough by Dr Jim Allison Nobel Prize winner - we look into the Ipi /Nivo treatment, a two pronged attack on reactivating the T-Cell
What are Biomarkers
Biomarkers may be used to better understand some of the characteristics of your cancer. Getting tested for biomarkers helps your doctor decide what options are right for you.
PD-1 / PD-L1 is the Checkpoint Pathway
Learn how simple the PD-1 / PD-L1 Pathway is to understand - 4 short videos from easy to technical
CCA Australia July 2022 Progress Update
A starting point for the next generation of cholangiocarcinoma patient success in Australia.
Intrahepatic Cholangiocarcinoma – Diagnosis and Treatment
Fralin Biomedical Research Institute Timothy Pawlik, M.D., Ph.D. dives deep into discovering and treating intrahepatic cholangiocarcinoma
World Cholangiocarcinoma Day
Contribution and Sharing are powerful human elements in the cancer cure equation - this is my contribution.
Treat the Immune not the Cancer
A breakthrough by Dr Jim Allison Nobel Prize winner - we look into the Ipi /Nivo treatment, a two pronged attack on reactivating the T-Cell
What are Biomarkers
Biomarkers may be used to better understand some of the characteristics of your cancer. Getting tested for biomarkers helps your doctor decide what options are right for you.
PD-1 / PD-L1 is the Checkpoint Pathway
Learn how simple the PD-1 / PD-L1 Pathway is to understand - 4 short videos from easy to technical
